Dr. Reddy's gets CDSCO Panel Nod To Study weight loss drug Semaglutide injection Dr. Divya Colin18 Oct 2023 6:15 PM ISTNew Delhi: The drug major Dr. Reddy's Laboratories has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
Novo Nordisk India head eyes 2026 weight-loss drug Wegovy launch Roshni Dhar3 Oct 2023 3:24 PM ISTDanish drugmaker Novo Nordisk aims to bring its blockbuster weight-loss drug Wegovy to India in 2026, after securing regulatory approvals and ensuring...
Novo Nordisk eyes to bring blockbuster weight-loss drug Wegovy to India in 2026 Ruchika Sharma1 Oct 2023 1:00 PM ISTNovo charges more than $1300 in the U.S. for a monthly supply and about 300 euros ($317) a month in Germany.
USFDA says timeline for supply limits on Novo Nordisk weight loss drug Wegovy unclear Ruchika Sharma13 Sept 2023 2:30 PM ISTThe U.S. Food and Drug Administration has said it was not clear when supply of lower doses of Novo Nordisk's Wegovy would normalize, backtracking from...
Novo Nordisk unveils weight loss injection Wegovy in Britain Ruchika Sharma4 Sept 2023 2:30 PM ISTLondon: Novo Nordisk launched its weight-loss injection Wegovy in Britain on Monday, its second debut in Europe in just over a month as the drugmaker...
Novo Nordisk launches weight-loss drug Wegovy in Germany Ruchika Sharma31 July 2023 2:30 PM ISTDoctors say many Germans seeking to lose weight have already used Ozempic, a diabetes drug also made by Novo that is a lower dose version of the same...
Weight loss drug has hidden ingredient with cardiac side effects: FDA Dr. Kamal Kant Kohli15 Feb 2023 9:15 AM ISTThe US Food and Drug administration has issued a warning to the consumers that Alfia Weight Loss Capsules contain sibutramine, a controlled substance...
Bimagrumab a novel weight loss drug for patients of obesity with diabetes: JAMA Dr. Kamal Kant Kohli14 Jan 2021 12:15 PM ISTSILVER SPRING, Md. - Researchers have found in a new study that treatment with Bimagrumab is safe and effective for treating excess adiposity and...
